Recent advances in therapy for glioblastoma.
作者： Jennifer Clarke , Nicholas Butowski , Susan Chang
DOI: 10.1001/ARCHNEUROL.2010.5
关键词:
摘要: Glioblastoma is the most common primary malignant brain tumor in adults and is a challenging disease to treat. The current standard of care includes maximal safe surgical resection, …
sci-hub.se 参考文章(34)
則雄 荒木, What's going on 放射線 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. N Engl J Med. 2005; 352: 987-96. PMID: 15758009.--神経膠腫に対する治療として、放射線治療とテモゾロマイドの併用が世界的な標準的治療となりうることを示唆する論文 Mebio oncology. ,vol. 3, pp. 132- 134 ,(2006)
Matthew J. McGirt, Khoi D. Than, Jon D. Weingart, Kaisorn L. Chaichana, Frank J. Attenello, Alessandro Olivi, John Laterra, Lawrence R. Kleinberg, Stuart A. Grossman, Henry Brem, Alfredo Quiñones-Hinojosa, Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme Journal of Neurosurgery. ,vol. 110, pp. 583- 588 ,(2009) , 10.3171/2008.5.17557
Michael G Hart, Robert Grant, Ruth Garside, Gabriel Rogers, Margaret Somerville, Ken Stein, Chemotherapeutic wafers for High Grade Glioma. Cochrane Database of Systematic Reviews. ,(2008) , 10.1002/14651858.CD007294
Duane A. Mitchell, Peter E. Fecci, John H. Sampson, Immunotherapy of malignant brain tumors Immunological Reviews. ,vol. 222, pp. 70- 100 ,(2008) , 10.1111/J.1600-065X.2008.00603.X
Sandeep Kunwar, Michael D. Prados, Susan M. Chang, Mitchel S. Berger, Frederick F. Lang, Joseph M. Piepmeier, John H. Sampson, Zvi Ram, Philip H. Gutin, Robert D. Gibbons, Kenneth D. Aldape, David J. Croteau, Jeffrey W. Sherman, Raj K. Puri, Direct Intracerebral Delivery of Cintredekin Besudotox (IL13-PE38QQR) in Recurrent Malignant Glioma: A Report by the Cintredekin Besudotox Intraparenchymal Study Group Journal of Clinical Oncology. ,vol. 25, pp. 837- 844 ,(2007) , 10.1200/JCO.2006.08.1117
Duane A. Mitchell, John H. Sampson, Toward effective immunotherapy for the treatment of malignant brain tumors Neurotherapeutics. ,vol. 6, pp. 527- 538 ,(2009) , 10.1016/J.NURT.2009.04.003
M. Salazar Andres, B. Levy Hilton, Ondra Steven, Kende Meir, Scherokman Barbara, Brown Douglas, Mena Hernando, Martin Norman, Schwab Karen, Donovan Daniel, Dougherty David, Pulliam Morris, Ippolito Mark, Graves Maria, Brown Herbert, Ommaya Alex, Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. Neurosurgery. ,vol. 38, pp. 1096- 1104 ,(1996) , 10.1097/00006123-199606000-00006
Fabio M. Iwamoto, Howard A. Fine, Bevacizumab for Malignant Gliomas JAMA Neurology. ,vol. 67, pp. 285- 288 ,(2010) , 10.1001/ARCHNEUROL.2010.11
Ashwatha Narayana, Josh Yamada, Sean Berry, Priti Shah, Margie Hunt, Philip H. Gutin, Steven A. Leibel, Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. International Journal of Radiation Oncology Biology Physics. ,vol. 64, pp. 892- 897 ,(2006) , 10.1016/J.IJROBP.2005.05.067
Ingo K Mellinghoff, Maria Y Wang, Igor Vivanco, Daphne A Haas-Kogan, Shaojun Zhu, Ederlyn Q Dia, Kan V Lu, Koji Yoshimoto, Julie HY Huang, Dennis J Chute, Bridget L Riggs, Steve Horvath, Linda M Liau, Webster K Cavenee, P Nagesh Rao, Rameen Beroukhim, Timothy C Peck, Jeffrey C Lee, William R Sellers, David Stokoe, Michael Prados, Timothy F Cloughesy, Charles L Sawyers, Paul S Mischel, None, Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. The New England Journal of Medicine. ,vol. 353, pp. 2012- 2024 ,(2005) , 10.1056/NEJMOA051918